Item 3.02. Unregistered Sales of Equity Securities.

On January 17, 2023, Novo Integrated Sciences, Inc. (the "Company") issued 6,174,165 shares of common stock to certain note holders upon conversion of their notes.

Between January 18, 2023 and January 19, 2023, the Company issued 5,764,712 shares of common stock to certain note holders upon conversion of their notes.

Between January 20, 2023 and January 23, 2023, the Company issued 8,319,761 shares of common stock to certain note holders upon conversion of their notes.

Between January 24, 2023 and January 25, 2023, the Company issued 5,762,677 shares of common stock to certain note holders upon conversion of their notes. In addition, the Company issued 3,202,019 shares of common stock in exchange for certain non-voting special shares of Novo Healthnet Limited, a wholly owned subsidiary of the Company, previously issued in connection with NHL's acquisition of Acenzia Inc. that closed on June 24, 2021.

Following such issuances, as of January 25, 2023, the Company's issued and outstanding common share count is 88,861,193.

© Edgar Online, source Glimpses